Synergy Pharmaceuticals Offers Update On Ongoing Irritable Bowel Syndrome With Constipation Program
July 15, 2016 at 10:26 AM EDT
Synergy Pharmaceuticals Inc (NYSE: SGYP) revealed that it reached the FDA mid-cycle review milestone for the plecanatide new drug ...